Tuberculosis Therapeutics Market Size, Share & Trends Report

Tuberculosis Therapeutics Market Size, Share & Trends Analysis Report by Disease Type (Active TB, Latent TB), By Therapy (First-Line, Second-Line), By Region, Competitive Landscape, And Segment Forecasts, 2018 - 2025

  • Published Date: May 2018
  • Report ID: GVR-2-68038-500-7
  • Number of Pages: 140
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016

Table of Contents

Chapter 1 Research Methodology & Scope
                 1.1 Information Procurement
                     1.1.1 Purchased database:
                     1.1.2 GVR’s internal database
                 1.2 Research Methodology
                 1.3 Geographic scope & assumptions
                 1.4 Region-wise market calculation
                     1.4.1 Region-wise market: Base estimates
                     1.4.2 Global market: CAGR calculation
                 1.5 Region-based segment share calculation
                 1.6 List of Secondary Sources
Chapter 2 Executive Summary
                 2.1 Market Snapshot
Chapter 3 Market Variables, Trends & Scope
                 3.1 Market segmentation & scope
                     3.1.1 Market Drivers Analysis
                         3.1.1.1 Global plan against drug-resistant TB drives diagnosis and treatment enrollment
                         3.1.1.2 HIV burden fuels LTBI case counts
                     3.1.2 Market Restraints Analysis
                         3.1.2.1 High drug cost
                         3.1.2.2 Poor regulation and lack of awareness in developing countries
                 3.2 Penetration & growth prospect mapping
                 3.3 Tuberculosis Drugs/Therapeutics Market - SWOT Analysis, By Factor (political & legal, economic and technological)
                 3.4 Industry Analysis - Porter’s
Chapter 4 Tuberculosis Drugs/Therapeutics Market: Therapy Type & Trend Analysis
                 4.1 Tuberculosis Drugs/Therapeutics Market: Therapy Type Movement Analysis
                     4.1.1 First-Line Therapy
                         4.1.1.1 First-line therapy market, 2014 - 2025 (USD Million)
                     4.1.2 Second-Line Therapy
                         4.1.2.1 Second-line therapy market, 2014 - 2025 (USD Million)
Chapter 5 Tuberculosis Drugs/Therapeutics Market: Disease Type & Trend Analysis 
                 5.1 Latent TB
                     5.1.1 Latent TB Drugs/Therapeutics market, 2014 - 2025 (USD Million)
                 5.2 Active TB
                     5.1.2 Active TB Drugs/Therapeutics market, 2014 - 2025 (USD Million)
Chapter 6 Market Categorization 2: Regional Estimates & Trend Analysis
                 6.1 Tuberculosis Drugs/Therapeutics Market Share, By Region, 2014 & 2025
                 6.2 North America
                     6.2.1. North America tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
                     6.2.2 U.S.
                         6.2.2.1 U.S. tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
                     6.2.3 Canada
                         6.2.3.1 Canada tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD million)
                 6.3 Europe
                     6.3.1 Germany
                         6.3.1.1 Germany tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
                     6.3.2 France
                         6.3.2.1 France tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
                     6.3.3 UK
                         6.3.3.1 UK tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
                 6.4 Asia Pacific
                     6.4.1 Asia Pacific tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
                     6.4.2 India
                         6.4.2.1 India tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
                     6.4.3 China
                         6.4.3.1 China tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
                     6.4.4 Philippines
                         6.4.4.1 Philippines tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
                 6.5 Latin America
                     6.5.1 Latin America tuberculosis Drugs/Therapeutics market, 2014 - 2026 (USD Million)
                     6.5.2 Brazil
                         6.5.2.1 Brazil tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
                     6.5.3 Mexico
                         6.5.3.1 Mexico tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
                 6.6 Middle East & Africa
                     6.6.1 Africa tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
                     6.6.2 South Africa
                         6.6.2.1 South Africa tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
                     6.6.3 Nigeria
                         6.6.3.1 Nigeria tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
Chapter 7 Competitive Landscape
                 7.1 Strategy framework
                 7.2 Market participation categorization
                 7.3 Company Profiles
                     7.3.1 Johnson & Johnson Services, LLC
                         7.3.1.1 Company overview
                         7.3.1.2 Financial performance
                         7.3.1.3 Product overview
                         7.3.1.4 Business strategies
                         7.3.1.5 SWOT analysis (Johnson & Johnson Services, LLC)
                     7.3.2 Lupin
                         7.3.2.1 Company overview
                         7.3.2.2 Financial performance
                         7.3.2.3 Product Overview
                         7.3.2.4 Business growth strategies
                         7.3.2.5 SWOT analysis (Lupin)
                     7.3.3 Novartis AG
                         7.3.3.1 Company overview
                         7.3.3.2 Financial performance
                         7.3.3.3 Product overview
                         7.3.3.4 Business strategies
                         7.3.3.5 SWOT analysis (Novartis AG)
                     7.3.4 Macleods Pharmaceuticals Ltd.
                         7.3.4.1 Company overview
                         7.3.4.2 Financial performance
                         7.3.4.3 Product overview
                         7.3.4.4 Business strategies
                         7.3.4.5 SWOT analysis (Macleods Pharmaceuticals Ltd)
                     7.3.5 Otsuka Pharmaceutical Co., Ltd.
                         7.3.5.1 Company overview
                         7.3.5.2 Financial performance
                         7.3.5.3 Product Overview
                         7.3.5.4 Business strategies
                         7.3.5.5 SWOT analysis (Otsuka Pharmaceuticals)
                     7.3.6 Pfizer
                         7.3.6.1 Company overview
                         7.3.6.2 Financial performance
                         7.3.6.3 Product overview
                         7.3.6.4 Business Strategies
                         7.3.6.5 SWOT analysis (Pfizer)
Chapter 8 Market Outlook
                 7.1 Market Scenario
                 7.2 Pipeline Analysis
                     7.2.1 Repurposed Drugs/Therapeutics
                     7.2.2 Current Regimen Trials
                     7.2.3 Promising Therapies


List of Tables

TABLE 1 North America tuberculosis Drugs/Therapeutics market, by country, 2014 - 2025 (USD Million)
TABLE 2 North America tuberculosis Drugs/Therapeutics market, by disease type, 2014 - 2025 (USD Million)
TABLE 3 North America tuberculosis Drugs/Therapeutics market, by therapy type, 2014 - 2025 (USD Million)
TABLE 4 U.S. tuberculosis Drugs/Therapeutics market, by disease type, 2014 - 2025 (USD Million)
TABLE 5 U.S. tuberculosis Drugs/Therapeutics market, by therapy type, 2014 - 2025 (USD Million)
TABLE 6 Canada tuberculosis Drugs/Therapeutics market, by disease type, 2014 - 2025 (USD Million)
TABLE 7 Canada tuberculosis Drugs/Therapeutics market, by therapy type, 2014 - 2025 (USD Million)
TABLE 8 Europe tuberculosis Drugs/Therapeutics market, by country, 2014 - 2025 (USD Million)
TABLE 9 Europe tuberculosis Drugs/Therapeutics market, by disease type, 2014 - 2025 (USD Million)
TABLE 10 Europe tuberculosis Drugs/Therapeutics market, by therapy type, 2014 - 2025 (USD Million)
TABLE 11 Germany tuberculosis Drugs/Therapeutics market, by disease type, 2014 - 2025 (USD Million)
TABLE 12 Germany tuberculosis Drugs/Therapeutics market, by therapy type, 2014 - 2025 (USD Million)
TABLE 13 France tuberculosis Drugs/Therapeutics market, by disease type, 2014 - 2025 (USD Million)
TABLE 14 France tuberculosis Drugs/Therapeutics market, by therapy type, 2014 - 2025 (USD Million)
TABLE 15 U.K. tuberculosis Drugs/Therapeutics market, by disease type, 2014 - 2025 (USD Million)
TABLE 16 U.K. tuberculosis Drugs/Therapeutics market, by therapy type, 2014 - 2025 (USD Million)
TABLE 17 Statistics for TB in high burden countries in APAC region, 2016
TABLE 18 Asia Pacific tuberculosis Drugs/Therapeutics market, by country, 2014 - 2025 (USD Million)
TABLE 19 Asia Pacific tuberculosis Drugs/Therapeutics market, by disease type, 2014 - 2025 (USD Million)
TABLE 20 Asia Pacific tuberculosis Drugs/Therapeutics market, by therapy type, 2014 - 2025 (USD Million)
TABLE 21 India tuberculosis Drugs/Therapeutics market, by disease type, 2014 - 2025 (USD Million)
TABLE 22 India tuberculosis Drugs/Therapeutics market, by therapy type, 2014 - 2025 (USD Million)
TABLE 23 China tuberculosis Drugs/Therapeutics market, by disease type, 2014 - 2025 (USD Million)
TABLE 24 China tuberculosis Drugs/Therapeutics market, by therapy type, 2014 - 2025 (USD Million)
TABLE 25 Philippines tuberculosis Drugs/Therapeutics market, by disease type, 2014 - 2025 (USD Million)
TABLE 26 Philippines tuberculosis Drugs/Therapeutics market, by therapy type, 2014 - 2025 (USD Million)
TABLE 27 Latin America TB cases, 2013
TABLE 28 Latin America tuberculosis Drugs/Therapeutics market, by country, 2014 - 2025 (USD Million)
TABLE 29 Latin America tuberculosis Drugs/Therapeutics market, by disease type, 2014 - 2025 (USD Million)
TABLE 30 Latin America tuberculosis Drugs/Therapeutics market, by therapy type, 2014 - 2025 (USD Million)
TABLE 31 Brazil tuberculosis Drugs/Therapeutics market, by disease type, 2014 - 2025 (USD Million)
TABLE 32 Brazil tuberculosis Drugs/Therapeutics market, by therapy type, 2014 - 2025 (USD Million)
TABLE 33 Mexico tuberculosis Drugs/Therapeutics market, by disease type, 2014 - 2025 (USD Million)
TABLE 34 Mexico tuberculosis Drugs/Therapeutics market, by therapy type, 2014 - 2025 (USD Million)
TABLE 35 Africa tuberculosis Drugs/Therapeutics market, by country, 2014 - 2025 (USD Million)
TABLE 36 Africa tuberculosis Drugs/Therapeutics market, by disease type, 2014 - 2025 (USD Million)
TABLE 37 Africa tuberculosis Drugs/Therapeutics market, by therapy type, 2014 - 2025 (USD Million)
TABLE 38 South Africa tuberculosis Drugs/Therapeutics market, by disease type, 2014 - 2025 (USD Million)
TABLE 39 South Africa tuberculosis Drugs/Therapeutics market, by therapy type, 2014 - 2025 (USD Million)
TABLE 40 Nigeria tuberculosis Drugs/Therapeutics market, by disease type, 2014 - 2025 (USD Million)
TABLE 41 Nigeria tuberculosis Drugs/Therapeutics market, by therapy type, 2014 - 2025 (USD Million)


List of Figures

FIG. 1 Market summary 2016, (USD Million)
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Average treatment cost, per case (2016 USD), in the U.S.
FIG. 12 Penetration & growth prospect mapping
FIG. 13 Tuberculosis Drugs/Therapeutics market - PESTLE analysis
FIG. 14 Porter’s five forces analysis
FIG. 15 Drugs/Therapeutics in development for tuberculosis
FIG. 16 Tuberculosis Drugs/Therapeutics market, Therapy outlook: Key takeaways
FIG. 17 Tuberculosis Drugs/Therapeutics market: Therapy movement analysis
FIG. 18 Treatment of tuberculosis in adult and children
FIG. 19 First-line Drugs/Therapeutics market, 2014 - 2025 (USD Million)
FIG. 20 Treatment of tuberculosis with second-line Drugs/Therapeutics
FIG. 21 Second-line therapy market, 2014 - 2025 (USD Million)
FIG. 22 Tuberculosis Drugs/Therapeutics market: Disease type movement analysis
FIG. 23 LTBI treatment regimen
FIG. 24 Latent TB Drugs/Therapeutics market, 2014 - 2025 (USD Million)
FIG. 25 Active TB Drugs/Therapeutics market, 2014 - 2025 (USD Million)
FIG. 26 Regional market place: Key takeaways
FIG. 27 Tuberculosis Drugs/Therapeutics market: Regional outlook, 2014 & 2025
FIG. 28 North America tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
FIG. 29 U.S. tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
FIG. 30 Canada tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD million)
FIG. 31 Europe tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
FIG. 32 Germany tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
FIG. 33 France tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
FIG. 34 U.K. tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
FIG. 35 Asia Pacific tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
FIG. 36 India tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
FIG. 37 China Tuberculosis Drugs/Therapeutics Market, 2014 - 2025 (USD Million)
FIG. 38 Philippines Tuberculosis Drugs/Therapeutics Market, 2014 - 2025 (USD Million)
FIG. 39 Latin America tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
FIG. 40 Brazil tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
FIG. 41 Mexico tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
FIG. 42 Africa tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
FIG. 43 South Africa tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
FIG. 44 Nigeria tuberculosis Drugs/Therapeutics market, 2014 - 2025 (USD Million)
FIG. 45 Strategy framework
FIG. 46 SWOT analysis (Johnson & Johnson)
FIG. 47 SWOT analysis (Lupin)
FIG. 48 SWOT analysis (Novartis AG)
FIG. 49 SWOT analysis (Macleods Pharmaceuticals Ltd)
FIG. 50 SWOT Analysis (Otsuka Pharmaceuticals)
FIG. 51 SWOT analysis (Pfizer)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.